Stay updated with breaking news from Late Breaking Science Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Baseline characteristics from FINE-HEART analysis highlight complex interplay between cardiovascular, kidney, and metabolic health, with over 92% of patients presenting two or more conditions
/PRNewswire/ -- DelveInsight's Acute Myocardial Infarction Market Insights report includes a comprehensive understanding of current treatment practices, acute...
(2023-11-12 | NDAQ:LXRX) INPEFA® (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical Data
Oral presentation delivered at the American Heart Association (AHA) Scientific Sessions 2023 Analysis of clinical data shows statistically significant risk reductions in heart failure and separately in MACE related outcomes as early as approximately three months in patients at high risk for cardiovascular events INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure THE WOODLANDS, Texas, Nov. 12, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today
Oral presentation delivered at the American Heart Association Scientific Sessions 2023 Analysis of clinical data shows statistically significant risk reductions in heart failure and separately in...